---
figid: PMC3674867__nihms473374f1
figtitle: 'Plasminogen Activator Inhibitor-1: The Double Edged Sword in Apoptosis'
organisms:
- NA
pmcid: PMC3674867
filename: nihms473374f1.jpg
figlink: /pmc/articles/PMC3674867/figure/F1/
number: F1
caption: The exact mechanism of PAI-1-regulated apoptosis is not clear and several
  different scenarios are possible. The uPA/uPAR/PAI-1 complex (1) in the presence
  of LRP is endocytosed (2). Intracellular PAI-1 can complex with caspase-3 leading
  to its inactivation promoting an anti-apoptotic effect (3), while uPAR and LRP are
  recycled to the cell surface (4). Alternatively, PAI-1 due to its interaction with
  LRP can transduce signaling intermediates inhibiting apoptosis (5a) by an unknown
  mechanism or promote survival by up-regulation of the c-jun/ERK pathway and anti-apoptotic
  proteins Bcl-2, Bcl-XL(5b). In a PAI-1 deficient state (6) there is sustained Akt
  activation resulting in increased levels of phosphorylated caspase-9 and increased
  levels of pro- or inactive caspase-3 promoting an anti-apoptotic state (7). Alternatively,
  PAI-1 can bind to vitronectin (8) competing with EC integrins and preventing binding
  of the cell to the matrix causing anoikis.
papertitle: 'Plasminogen Activator Inhibitor-1: The Double Edged Sword in Apoptosis.'
reftext: Rashna D. Balsara, et al. Thromb Haemost. ;100(6):1029-1036.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9432287
figid_alias: PMC3674867__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC3674867__F1
ndex: 685b16a6-df02-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3674867__nihms473374f1.html
  '@type': Dataset
  description: The exact mechanism of PAI-1-regulated apoptosis is not clear and several
    different scenarios are possible. The uPA/uPAR/PAI-1 complex (1) in the presence
    of LRP is endocytosed (2). Intracellular PAI-1 can complex with caspase-3 leading
    to its inactivation promoting an anti-apoptotic effect (3), while uPAR and LRP
    are recycled to the cell surface (4). Alternatively, PAI-1 due to its interaction
    with LRP can transduce signaling intermediates inhibiting apoptosis (5a) by an
    unknown mechanism or promote survival by up-regulation of the c-jun/ERK pathway
    and anti-apoptotic proteins Bcl-2, Bcl-XL(5b). In a PAI-1 deficient state (6)
    there is sustained Akt activation resulting in increased levels of phosphorylated
    caspase-9 and increased levels of pro- or inactive caspase-3 promoting an anti-apoptotic
    state (7). Alternatively, PAI-1 can bind to vitronectin (8) competing with EC
    integrins and preventing binding of the cell to the matrix causing anoikis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - scb
  - arr
  - upd1
  - Akt
  - Dronc
  - Jra
  - Erk7
  - rl
  - Debcl
  - BC1
  - bc2
  - an
  - Decay
  - VTN
  - SERPINE1
  - ITGA1
  - ITGA10
  - ITGA11
  - ITGA2
  - ITGA2B
  - ITGA3
  - ITGA4
  - ITGA5
  - ITGA6
  - ITGA7
  - ITGA8
  - ITGA9
  - ITGAD
  - ITGAE
  - ITGAL
  - ITGAM
  - ITGAV
  - ITGAX
  - ITGB1
  - ITGB2
  - ITGB3
  - ITGB4
  - ITGB5
  - ITGB6
  - ITGB7
  - ITGB8
  - ITGBL1
  - RPSA
  - LRP1
  - PTPRA
  - MVP
  - PLAU
  - PRAP1
  - PLAUR
  - AKT1
  - AKT2
  - AKT3
  - JUN
  - EPHB2
  - MAPK1
  - MAPK3
  - BCL2L1
  - BCL2
  - CHMP2A
  - BAX
  - AN
---
